Total System Services (TSS) - FREE Research Report

Lampton Mason H who is Director at Total System Services sold 1,889 shares at $30.80 on Nov. 19, 2013. Following this transaction, the Director owned 18,077 shares meaning that the stake was reduced by 9.46% with the 1,889 share transaction.

The shares most recently traded at $31.00, up $0.20, or 0.65% since the insider transaction. Historical insider transactions for Total System Services go as follows:

  • 4-Week # shares sold: 48,988
  • 12-Week # shares sold: 171,988
  • 24-Week # shares sold: 171,988

The average volume for Total System Services has been 1.1 million shares per day over the past 30 days. Total System Services has a market cap of $5.8 billion and is part of the financial sector and financial services industry. Shares are up 43.79% year to date as of the close of trading on Tuesday.

Total System Services, Inc. provides payment processing and other services to card-issuing and merchant acquiring institutions in the United States and internationally. It operates through three segments: North America Services, International Services, and Merchant Services. The stock currently has a dividend yield of 1.3%. The company has a P/E ratio of 24.4. Currently there are 7 analysts that rate Total System Services a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TSS - FREE

TheStreet Quant Ratings rates Total System Services as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, good cash flow from operations, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Total System Services Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Icahn Bets on Allergan's Brett Saunders in Post-Pfizer Era

What Bill Ackman's Voice Could Mean for the Valeant Board Room

What Bill Ackman's Voice Could Mean for the Valeant Board Room

Jim Cramer: There’s No Way We’ll See More Railroad M&A

Federal Reserve to Reassess Global Risks in Minutes on Wednesday

Can Allergan-Pfizer Survive Treasury's New Crackdown on Inversions?